Coronapod: Why COVID antibody treatments may not be the answer
In the early days of the pandemic, researchers raced to identify the most potent antibodies produced by the immune system in response to SAR-COV-2 infection and produce them in bulk. The resulting \u2018monoclonal antibodies\u2019 have since been tested in a variety of settings as treatments for COVID-19.
But despite promising clinical trial results and several therapies having already been approved, antibody therapies have not yet played a large role in the fight against COVID-19. In this episode of Coronapod, we ask why.
News: COVID antibody treatments show promise for preventing severe disease
\ufeffNews: Antibody therapies could be a bridge to a coronavirus vaccine \u2014 but will the world benefit?
Hosted on Acast. See acast.com/privacy for more information.